Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

Roser Pinyol, Josep M. Llovet, Laia Bassaganyas et al.|Gut|2018

Cited by 338